CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: HARRY GIBSON who wrote ()	1/29/1997 7:32:00 PM
From: indexer	of 666

They have a B-1 antigen based lymphoma treatment which is claimed to be particularly effective on Non-hodgkin's Lymphoma, in cases which have previously resisted treatment. Edgar/SEC documents available on-line. There is some competition. IPO opened @ 12, now @ ~ 12 1/2. Does anyone know who is making a market or following this stock? Besides the SEC filings, I got one hit searching by stock symbol, name or anything else I could think of: facts-online.com Stoner.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext